Page results
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
This page provides information about the investigation of and surgery to treat cancer of the oesophagus.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
The purpose of this page is to explain what an ectopic pregnancy is, what it means for your health, the different treatment options, risks involved in treatment, and potential risks in future pregnancies.
-
Dr Victoria Grandage is a consultant haematologist with research interests in acute myeloid leukaemia, non-malignant haematology, bone marrow transplantation and the late effects of cancer treatment.
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023
-
FOI/2024/0158 - Procedures cancelled due to issues with defective diagnostic equipment
-
FOI/2024/0169 - Medical emergency protocols
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0182 - Women diagnosed with Endometriosis 2019 to 2023